Track topics on Twitter Track topics that are important to you
Next-Generation Tablet Formulation Resists Physical Manipulation and Extraction of Hydrocodone In Vitro Data Supports Further Human Abuse Liability Studies LAS VEGAS, Sept. 9, 2015 (GLOBE NEWSW...
Zohydro (hydrocodone) is a single-entity oral drug indicated for the treatment of chronic pain. San Diego-based pharmaceutical company Zogenix developed and commercialised the drug in the US.
A method of biosynthesizing thebaine and hydrocodone in engineered yeast could provide an efficient alternative to synthetic methods that rely on plant-derived opium.
An immunoassay developed by Thermo Fisher Scientific has obtained 510(k) clearance from the FDA to detect hydrocodone, a freq -More-
A study conducted by Stanford researchers led by Christina Smolke developed a technique that can hasten the production of hydrocodone. Hydrocodone and its chemical relatives, such as morphine and oxyc...
Raptor Pharmaceutical has won FDA approval for the expanded use of delayed-release Procysbi, or cysteamine bitartrate, in ped -More-
To assess the single-dose and steady-state pharmacokinetics of a single-entity hydrocodone extended-release (ER) formulation in patients enrolled in two separate phase 2 clinical studies.
Evaluate levels of pain relief achieved in patients with chronic pain treated with hydrocodone-extended release (HC-ER) up to 48 weeks and show that these levels were associated with secondary functio...
OBJECTIVE To evaluate clinical efficacy of hydrocodone-acetaminophen and tramadol for treatment of postoperative pain in dogs undergoing tibial plateau leveling osteotomy (TPLO). ANIMALS 50 client-own...
OBJECTIVE To evaluate the pharmacokinetics of hydrocodone (delivered in combination with acetaminophen) and tramadol in dogs undergoing tibial plateau leveling osteotomy (TPLO). ANIMALS 50 client-owne...
To evaluate long-term safety of hydrocodone extended-release (ER) formulated with CIMA(®) Abuse-Deterrence Technology platform.